KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ·Healthcare·Biotechnology
$19.19
+0.16%
Mkt Cap $977.33M
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (7 analysts)
$32.33
Range $28.00 – $37.00
Implied Upside
+68.5%
Consensus $32.33 vs current $19.19
NASDAQ·Healthcare·Biotechnology
$19.19
+0.16%
Mkt Cap $977.33M
Buy
6
Hold
0
Sell
0
Price Target (7 analysts)
$32.33
Range $28.00 – $37.00
+68.5%
Consensus $32.33 vs current $19.19